info.3se@keehealthcare.com

Pigmentation

“Skin pigmentation disorders and irregularities are common. Hyperpigmentation problems are particularly prevalent and many are associated with aging. While the triggers may vary, hyperpigmentation occurs when pigment-producing cells (melanocytes) become more active than normal, which leads to the production and deposition of more pigment (melanin). Age spots / sun spots (solar lentigines) Age spots/sun spots (solar lentigines) are pigmented skin blemishes associated with aging, sun damage and, to a lesser degree, other forms of skin damage. They are sometimes erroneously called liver spots, which is misleading because they are unrelated to the liver and in no way reflect liver function. Age spots range in color from light brown to black and are predominantly located in areas exposed to the sun, such as hands, face, and arms. Treatments for Age Spots include – Deep and Medium Chemical Peel, Smoothbeam Laser, topical ointments and Surgical Dermabrasion. A customized treatment plan may include one treatment or a combination. Freckles Freckles (ephelides) are small, pigmented spots containing more melanin than the surrounding skin. Freckles are not caused by aging and/or sun damage. As opposed to age spots, freckles tend to fade with age. Sun exposure, while not a cause of freckles, typically makes freckles much more prominent. Freckles are found mainly in fair skinned people and tend to run in families. The cause of freckles appears to be largely genetic. Treatments for Freckles include – Deep and Medium Chemical Peel, topical ointments and Smoothbeam Laser. A customized treatment plan may include one treatment or a combination. Melasma Melasma is a condition characterized by increased tan-like skin pigmentation typically having uneven, patchy distribution. While hormonal changes seem to be the most common cause of melasma ,other factors may have a role. In particular, a combination of sun damage and certain ingredients found in deodorants, toiletry and other personal care products may result in melasma – apparently due to local sensitization of melanocytes. Treatments for Melasma include – An intense treatment plan using Deep and Medium Chemical Peels with topical ointments .”

How it works?

1.

Request for medicine

Patient who has serious problem request for medicine

 

2.

Drug Verify

Internal processing of drug verifications at GM Global

 

3.

Prescription

Recognizing best source for the specific prescription

 

4.

GDP Instruction

Import medicine under the GDP instruction

 

5.

QA check

Supply drugs to concerned healthcare provider after QA check

 

5.

QA check

Supply drugs to concerned healthcare provider after QA check

 

FAQ

A NPP provides access to post-approval drugs that are approved and commercially available in one or more country, other than the patient’s home country.

 

No. Companies are not required to provide their products through a formal NPP.

 

  • Dealing with unsolicited patient request for drug in an ethical and regulatory controlled manner
  • Providing exposure to, and experience with, company products to physicians in additional countries and build a larger KOL network and future advocates
  • Providing new products to patients who would move to commercial drug when it becomes available in these countries
  • Generating additional revenues in countries that allow you to charge for drugs supplied on a named patient basis

Companies can provide drug to patients in any country in which they have not yet received marketing approval. This includes countries in which a company plans to seek marketing approval, as well as those countries in which a company does not plan to seek marketing approval.

 
 

INFORMATION FOR PATIENTS

As a named patient medicines you may find yourself in the frightening position that you have a serious condition or illness and the treatment you need is not available in your home country. It is possible that the medicines are available outside your country and if your physician decides that these drugs would be suitable for the treatment of your illness, they then face the challenge of obtaining them for you. We help physicians across the world access medicines which are not approved or licensed in their country, but may be required to meet the special needs of an individual patient. The service we provide not only locates and supplies the required medicines but ensures that the physician has all the quality assurance and supporting clinical information they will need to safely prescribe it to you. If you are confronted with a situation where a drug is not available to you, talk to your physician or healthcare professional about Named Patient Program and ask them to contact us. We will then work directly with your physician to help them in patient access program and understand what options are available.

 

 

Drugs We Provide Under NPS

Drug Directory

Orphan Drugs

1.

Request for medicine

Patient who has serious problem request for medicine

 

2.

Drug Verify

Internal processing of drug verifications at GM Global

 

3.

Prescription

Recognizing best source for the specific prescription

 

4.

GDP Instruction

Import medicine under the GDP instruction

 

5.

QA check

Supply drugs to concerned healthcare provider after QA check

 

5.

QA check

Supply drugs to concerned healthcare provider after QA check

 

FAQ

A NPP provides access to post-approval drugs that are approved and commercially available in one or more country, other than the patient’s home country.

 

No. Companies are not required to provide their products through a formal NPP.

 

  • Dealing with unsolicited patient request for drug in an ethical and regulatory controlled manner
  • Providing exposure to, and experience with, company products to physicians in additional countries and build a larger KOL network and future advocates
  • Providing new products to patients who would move to commercial drug when it becomes available in these countries
  • Generating additional revenues in countries that allow you to charge for drugs supplied on a named patient basis

Companies can provide drug to patients in any country in which they have not yet received marketing approval. This includes countries in which a company plans to seek marketing approval, as well as those countries in which a company does not plan to seek marketing approval.

 
 

INFORMATION FOR PATIENTS

As a named patient medicines you may find yourself in the frightening position that you have a serious condition or illness and the treatment you need is not available in your home country. It is possible that the medicines are available outside your country and if your physician decides that these drugs would be suitable for the treatment of your illness, they then face the challenge of obtaining them for you. We help physicians across the world access medicines which are not approved or licensed in their country, but may be required to meet the special needs of an individual patient. The service we provide not only locates and supplies the required medicines but ensures that the physician has all the quality assurance and supporting clinical information they will need to safely prescribe it to you. If you are confronted with a situation where a drug is not available to you, talk to your physician or healthcare professional about Named Patient Program and ask them to contact us. We will then work directly with your physician to help them in patient access program and understand what options are available.